Cytomedix Inc. (CYDX) Secures Second DePuy Spine Licensing Agreement
10/19/2005 5:12:57 PM
ROCKVILLE, Md., March 8, 2005 (PRIMEZONE) -- Cytomedix, Inc. (OTCBB:CYME) today announced that it has entered into a second licensing agreement with DePuy Spine, Inc., a Johnson and Johnson company. The additional license of Cytomedix's Knighton patent (US Patent No. 5,165,938) is for all applications of its autologous platelet releasate therapy, excluding treatment of chronic wounds, such as pressure ulcers, venous stasis or diabetic foot ulcers.
The company also said that DePuy Spine's existing exclusive licensing agreement for spinal, orthopedic and neurosurgical applications would be converted to a non-exclusive license to practice in those fields. Financial details of the new agreement were not disclosed.
comments powered by